Klamroth, R., Wojciechowski, P., Aballéa, S., Diamand, F., Hakimi, Z., Nazir, J., . . . Tarantino, M. D. (2021). Efficacy of rFVIIIFc versus Emicizumab for the Treatment of Patients with Hemophilia A without Inhibitors: Matching-Adjusted Indirect Comparison of A-LONG and HAVEN Trials. J Blood Med.
Chicago-stil citatKlamroth, Robert, et al. "Efficacy of RFVIIIFc Versus Emicizumab for the Treatment of Patients With Hemophilia A Without Inhibitors: Matching-Adjusted Indirect Comparison of A-LONG and HAVEN Trials." J Blood Med 2021.
MLA-referensKlamroth, Robert, et al. "Efficacy of RFVIIIFc Versus Emicizumab for the Treatment of Patients With Hemophilia A Without Inhibitors: Matching-Adjusted Indirect Comparison of A-LONG and HAVEN Trials." J Blood Med 2021.